Fluorine-18-α-Methyltyrosine Positron Emission Tomography to Measure Therapy
N/A
20 Years
N/A
20 Years
N/A
Not Enrolling
Both
Non-Small Cell Lung Cancer
Both
Non-Small Cell Lung Cancer
Trial Information
Fluorine-18-α-Methyltyrosine Positron Emission Tomography to Measure Therapy
Inclusion Criteria:
- primary lung cancer All patients received first-line chemotherapy
Exclusion Criteria:
- Patients with diabetus mellitus
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Authority:
Japan: Ministry of Health, Labor and Welfare
Study ID:
Mol Imaing 1
NCT ID:
NCT00826033
Start Date:
Completion Date:
Related Keywords:
- Non-Small Cell Lung Cancer
- Fluorine-18-α-methyltyrosine
- Positron emission tomography
- Lung cancer
- chemotherapy
- monitoring
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
